In this series we examine the future of the medical device industry—from manufacturing to the consumer-patient experience.
A mere 13% of IoMT leaders believe their organization is in a good place to mitigate future risks related to cybersecurity.
With the accelerated adoption of many new technologies, ECRI’s annual health technology hazards list has been transformed by the COVID-19 pandemic.
During this week’s Consumer Electronics Show, FDA Principal Deputy Commissioner Amy Abernathy talks about lessons learned from the pandemic and 2021 goals.
Its success lies in a synergy between the technological and the clinical.
Leveraging the power of technology to create a more patient-centric approach and consolidate costs is expected to play a big role.
The challenge for the digital health community will be to bring the same high standards for care in the physical world to their digital interactions.
The technology behind remote cardiac device monitoring is becoming more convenient, responsive and connected across the digital ecosystem—including a new smartphone app.
No longer just “the big company advantage,” CM&S is an accepted and viable device industry path to market for large and small medical device makers alike.
And medtech companies need to keep interoperability and security top of mind.